ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
97 760,09
-0,35%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX

  6. Medivation (MDV) Cours

Medivation

Medivation (MDV)

Modiv Industrial Inc
Megastar Development Corp
0,00
0,00
(0,00%)
Fermé 04 Janvier 10:00PM
Retardé de 15 minutes
0,00
0,00
(0,00%)
Après les heures de négociation: -
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
-
Prix Achat
-
Prix Vente
-
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
-
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

MDV Dernières nouvelles

Plus de nouvelles

Medivation Common Stock Begins Trading on Nasdaq Global Market Under the Symbol 'MDVN'

SAN FRANCISCO, March 20 /PRNewswire-FirstCall/ -- Medivation, Inc. (NASDAQ:MDVN) today announced that its common stock will begin trading on The Nasdaq Global Market under the symbol MDVN at the...

20 Mars 2007
PR Newswire (US)

Medivation Announces Presentation of Full Top-Line Data From Dimebon(TM) Six-Month Trial at Major International Alzheimer's Dise

SAN FRANCISCO, March 19 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that six-month results from its randomized, double-blinded, placebo-controlled Phase 2 efficacy...

19 Mars 2007
PR Newswire (US)

Dutton Associates Announces Investment Opinion: Medivation Strong Speculative Buy Rating In Update Coverage By Dutton Associates

Dutton Associates continues its coverage of Medivation Inc. (AMEX:MDV) reiterating a Strong Speculative Buy rating and a $27.00 price target. The 12-page report by Dutton senior...

15 Mars 2007
Business Wire

Medivation Common Stock Approved for Listing on the Nasdaq Global Market

SAN FRANCISCO, March 8 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that The Nasdaq Listing Qualifications Department has approved the Company's application to list its...

08 Mars 2007
PR Newswire (US)

Medivation to Present at Cowen and Company's 27th Annual Healthcare Conference

SAN FRANCISCO, March 5 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that David Hung, M.D., president and chief executive officer, will present at Cowen and Company's...

05 Mars 2007
PR Newswire (US)

Medivation's MDV3100 Shown to Be Effective in a Preclinical Model of Hormone-Refractory Prostate Cancer

- Data Presented in Oral and Poster Presentations at ASCO's Prostate Cancer Symposium - SAN FRANCISCO, Feb. 26 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that results...

26 Février 2007
PR Newswire (US)

Preclinical Efficacy Data on Medivation's MDV3100 to Be Presented at ASCO-sponsored Prostate Cancer Symposium

SAN FRANCISCO, Feb. 16 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that preclinical efficacy data on MDV3100, a novel small molecule the Company is developing to treat...

16 Février 2007
PR Newswire (US)

Medivation to Present at BIO CEO & Investor Conference 2007

SAN FRANCISCO, Feb. 5 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that David Hung, M.D., president and chief executive officer, will present at the 9th Annual BIO CEO...

05 Février 2007
PR Newswire (US)

Medivation's Dimebon(TM) Phase 2 Trial Results to be Presented at 8th International Conference on Alzheimer's and Parkinson's Di

SAN FRANCISCO, Jan. 30 /PRNewswire-FirstCall/ -- Medivation, Inc. (AMEX:MDV) today announced that results of its Phase 2 efficacy study of Dimebon(TM) in Alzheimer's disease will be presented at...

30 Janvier 2007
PR Newswire (US)

Medivation Names Lisa Taylor Vice President of Commercial Development

SAN FRANCISCO, Jan. 17 /PRNewswire/ -- Medivation, Inc. (AMEX:MDV) today announced that it has appointed Lisa Taylor as vice president of commercial development. Ms. Taylor is responsible for...

17 Janvier 2007
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

MDV - Frequently Asked Questions (FAQ)

What is the current share price?
The current share price of is US$ 0,00
What is the 1 year trading range for share price?
has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
SCPXScorpius Holdings Inc
US$ 0,54
(56,39%)
92,65M
EVAVDirexion Daily Electric and Autonomous Vehicles Bull 2x Shr
US$ 31,47
(41,93%)
67,51k
YCBDcbdMD Inc
US$ 0,5664
(36,81%)
10,52M
SYNXSilynxcom Ltd
US$ 4,98
(27,12%)
768,02k
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 10,21
(25,43%)
48,74M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 19,24
(-26,06%)
16,46M
ITPIT Tech Packaging Inc
US$ 0,5227
(-21,99%)
1,83M
ATCHAtlasClear Holdings Inc
US$ 8,11
(-19,30%)
246,19k
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2,35
(-15,92%)
59,36M
BURUNuburu Inc
US$ 0,6771
(-15,36%)
2,27M
SCPXScorpius Holdings Inc
US$ 0,54
(56,39%)
92,65M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 29,82
(7,77%)
72,12M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6,10
(-3,63%)
60,33M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2,35
(-15,92%)
59,36M
MSTUT Rex 2X Long MSTR Daily Target ETF
US$ 10,21
(25,43%)
48,74M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

AMEX
MDV
BIT
SUSC
SSgA SPDR ETFs EUROPE I ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés